• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Rennee Rayburg, RPh, Discusses the Top Down Approach in Specialty Drug Management

Article

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

When providers only focus on their top drivers, they fail to recognize the impact specialty drug patients can have on pushing higher costs. Rayburg says, “When you look at a rare disease and a drug that might cost you a couple hundred thousand dollars a year, it’s going to make a difference if you have one or two of those in your population of people.”

Related Videos
Dr Steven Manobianco
Dr David Kuter
Roy Mathew, MD, screenshot
Dr Marco del Riccio
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Dr David Kuter
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
© 2026 MJH Life Sciences
AJMC®
All rights reserved.